Technologies

We propose a portable chemical analysis system capable of identifying chemical substances at trace concentrations (sub-ppm), even in case of a complex matrix of interfering species.

We offer integrated tools for the acquisition, analysis, modelling and optimization of visitor flows in museums characterized by frequent congestion and/or complex geometries. Our intervention is divided into 4 phases:

1) Data acquisition related to the paths followed by visitors in the museum, number of visitors in the rooms, time of permanence, ... The acquisition is performed via a specific IoT system, smartphone app or manual counting.

Recently, nanoparticles and nanovesicles have been investigated as potential approaches for the treatment of neurodegenerative diseases. In particular, in the Biotech sector an increasingly deeper penetration of new treatment models and biological drugs based on cellular, subcellular and vesicle therapies is expected. The patent is based on the production of Myelin-based nanoVesicles (MyVes) produced by microfluidics, starting from myelin extracted from brain tissue. These vesicles find two major fields of applications as potential drugs or as supplements/nutraceuticals.

Filamentous bacteriophages for size, in vivo biodistribution and easiness of engineering, are considered as natural nanoparticles. The developed technology allows the construction of bio-nanoparticles based on filamentous bacteriophages delivering proteic antigens and immunomodulating lipids. Thanks to the high content of hydrophobic residues, phage capsid proteins have high binding affinity to lipids, allowing the conjugation of immunostimulating lipids.

An interoperable and modular Digital Geospatial Ecosystem (DGE) is proposed, designed, implemented and tested in order to: collect in real time, manage and share geographic data; make usable tools and functionalities to support actions to prevent, monitor and mitigate impacts from extreme events as well as to prepare for and respond to emergency situations. The DGE is composed of the following modules:

Safe, efficient and specific nano-delivery systems are increasingly needed for precision and regenerative medicine and targeted therapies (e.g. anticancer and antimicrobial therapies), as well as for  the cosmetic and nutraceutical sectors’ applications. Despite the appreciable success of synthetic nanovectors, like for example liposomes, their clinical and market application is hampered by some limitations: • large scale production, • low cost production • intrinsic toxicity • limited cellular uptake • limited consumer acceptance.